NSE BCG – The Brightcom Group share prices already touched 52 week lows Rs-9.35 on 2nd May 2023 from the 52 week high price – 81.30 on 4th May 2022 without any allegations proof. As SEBI had shown Show cause regarding accounting irregularities but till now it has not proved whether irregularities done or not. Brightcom Group gives proper clarification to SEBI according with SEBI’s Show cause notice.
Brightcom Group shares have been under pressure since the SEBI sent a notice to show cause. It also raised questions about the irregularity and inaccuracy of the filings for Brightcom Group’s shareholding patterns. SEBI said that the numbers had been recorded incorrectly, in violation of the rules.
Company has shown all the subsidiaries result in their website and shareholding pattern – you can visit to Brightcom group website – https://www.brightcomgroup.com/investors/subsidiaries-financials/
SEBI arise issued the financial year 2014 to 2020 and mentioned company balance sheet and P/L shown overstated profit. Now we are looking that company shows Loss in the year 2020 for all subsidiaries result according with website but company making handsome profit after 2020 and future corpus is very bright.
All the fake news scattered by youtuber in youtube. Many youtuber shows wrong information about Brightcom group news without any proper knowledge, making 5-6 videos in a day on bcg for creating more subscriber.
The shares of Brightcom Group Ltd hit the upper limits circuit on Thursday in the early trading for the third consecutive session this week.
Stocks have gained in the last three sessions due to the news that Dr Surabhi Sinha was reappointed for another five years as a director.
Stock was restricted to a 5% upper limit after opening at an intraday high price of Rs 10.72 per share at BSE.
The stock has risen by 15% in the last three trading days.
On Friday, April 28th, the stock touched a low of Rs9.27 and finished at Rs9.35. This is a 5% decline.
In an exchange filing, the company said that Dr Surabhi Sinha’s reappointment as ‘Additional Directors in the category Non-Executive-Independent Director’ for a five-year period beginning February 12, 2023 is subject to approval from the Company’s Shareholders through a Special Resolution at the next General Body Meeting of the Members.
Sinha’s term will end on February 12, 2023. The company also stated that Sinha had no relation to any of the directors.
The company added in its filing to the exchange that “we confirm that Dr Surabhi Sinha has not been barred from holding the position of Director at the Company by virtue of any SEBI or other authority.”
The stock traded at a high volume of 47,3 million shares during today’s session. The stock price fell 86.5% in the last year and the sector underperformed by 76.9%.